Diagnostic accuracy of adropin as a preliminary test to exclude acute pulmonary embolism: a prospective study

BACKGROUND: This study aims to investigate the diagnostic accuracy of adropin as a biomarker to exclude the diagnosis of acute pulmonary embolism (PE). METHODS: Patients admitted to the emergency department of a tertiary health centre between August 2019 and August 2020 and diagnosed with PE were in...

Descripción completa

Detalles Bibliográficos
Autores principales: Orun, Serhat, Celikkol, Aliye, Basol, Batuhan Ilbey, Yeniay, Elif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482749/
https://www.ncbi.nlm.nih.gov/pubmed/36115957
http://dx.doi.org/10.1186/s12890-022-02156-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482749/
https://www.ncbi.nlm.nih.gov/pubmed/36115957
http://dx.doi.org/10.1186/s12890-022-02156-y

Ejemplares similares